NCT03709082 2024-03-05Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast CancerUniversity of Kansas Medical CenterPhase 1/2 Terminated3 enrolled